USFDA
-
Opportunity India Desk May 30 2022 - 3 min readStrides Pharma Science said that its step-down wholly owned subsidiary company Strides Pharma Global, Singapore has received nod for Ibuprofen oral suspension USP, 100 mg/5 mL from the United States Food & Drug Administration (USFDA).The product is bioequivalent and therapeutically equivalent to the Reference Listed Drug (RLD), Motrin oral suspension, 100 mg/5 mL ...
-
Franchise India Bureau Aug 07 2018 - 1 min readDrug major Cipla today said it has received final approval from the United States Food and Drug Administration (USFDA) for Diclofenac Sodium Topical Gel, indicated for the relief of the pain of osteoarthritis of joints such as the knees and hands. Diclofenac Sodium Topical Gel, 1 per cent is a generic therapeutic equivalent to the ...
-
Franchise India Bureau Aug 06 2018 - 1 min readDrug firm Sanofi run speciality care global business unit Sanofi Genzyme has launched its multiple sclerosis treatment drug Aubagio in India. Patients diagnosed with multiple sclerosis are offered the convenience of once-a-day oral treatment, Sanofi Genzyme said in a statement. Commenting on the development, Sanofi India MD N Rajaram said, "For over a decade Sanofi ...
-
Franchise India Bureau Jul 30 2018 - 1 min readUS based Drug maker Lupin has received a go ahead signal from European Directorate for the Quality of Medicines (EDQM) for its Mandideep facility in Madhya Pradesh. According to Lupin, the facility inspected by EDQM in March this. "The inspection was focused on the application for certificate of suitability for the dossier of Cefaclor along with ...
-
Franchise India Bureau Jul 25 2018 - 1 min readSun Pharmaceutical Industries today said one of its wholly owned subsidiaries has launched generic metformin hydrochloride extended release tablets, used for glycemic control, in the US market. The tablets have been launched in the strengths of 500 mg and 1000 mg, it said in a filing to BSE. The tablets are generic versions of Santarus ...